ArticleInternational journal of molecular sciences2024

Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets.

Lucrezia Irene Maria Campagnoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.